DUBLIN--(BUSINESS WIRE)--The "EPA
& DHA Market - Segmented by Type, Concentration, Form, Source,
Application (Infant Formulae, Dietary Supplements, Fortified Food and
Beverages, Pharmaceuticals) and Geography - Growth, Trends and Forecasts
(2018 - 2023)" report has been added to ResearchAndMarkets.com's
offering.
The global EPA & DHA market is expected to register a CAGR of 9.7%
during the forecast period, 2018 to 2023.
EPA and DHA are gaining importance and becoming a part of the consumer's
daily diet. The key reasons for this change have been the increased
prevalence of lifestyle diseases and people taking preventive healthcare
measures.
Moreover, emerging applications of EPA and DHA in food, dietary
supplements, and clinical nutrition are further stimulating the market
growth.
The market is budding, owing to growing information about the advantages
of consuming supplements and functional food enriched with omega-3 fatty
acids, among consumers.
Asia-Pacific and North America, together contributed more market share
followed by Middle East & Africa owing to the consumer awareness in the
developing countries.
Robust Demand from Health Conscious Consumers Boost Growth
The increased awareness about EPA and DHA has resulted in an increase in
application of these ingredients across several end-user industry and
markets for direct human consumption. In addition, the most rapidly
emerging applications of EPA and DHA are in food, dietary supplements,
and clinical nutrition. Most of these sectors demand EPA and DHA with
high purity and concentration.
EPA and DHA has various benefits over health, such as preventing
cardiovascular diseases by reducing triglyceride level, reducing
obesity, bone health, inflammatory health and increasing immunity.
Moreover, the EPA and DHA have been proven to help overweight
individuals by contributing to the improvement of body composition by
increasing metabolism and fat burning potential. They also help in
suppressing appetite, which leads to the consumption of fewer calories.
However, fluctuating costs and mild side effects of EPA and DHA
supplements that includes unpleasant taste, bad breath, bad-smelling
sweat, headache, and gastrointestinal symptoms, such as heartburn,
nausea, and diarrhea, are limiting the consumers from choosing EPA and
DHA-based products.
Competitive Landscape The key brands in EPA and DHA
market are embarking on mergers and acquisitions and new product
development as some of their key strategies to achieve consolidation and
optimize their offerings respectively.
Major players in the market are Royal DSM, Croda International, Omega
Protein Corporation, Corbion, BASF SE, and Pelagia AS among many others.
Key Topics Covered
1. Introduction
2. Market Insights
3. Market Dynamics
4. Market Segmentation
5. EPA & DHA Market By Geography
6. Market Competitive Landscape
7. Company Profiles
-
Royal DSM
-
Croda International
-
Omega Protein Corporation
-
Archer Daniels Midland Company
-
Corbion
-
BASF SE
-
Pelagia AS
-
Golden Omega S.A.
-
Arctic Nutrition AS
-
Organic Technologies
-
KD Pharma Group
-
Novotech Nutraceuticals Inc.
-
Novasep Holding SAS
For more information about this report visit https://www.researchandmarkets.com/research/44qx7t/the_global_epa?w=4